Neural and Mobile Assessment OF Behavior Change Among Problem Drinkers

NCT ID: NCT03457077

Last Updated: 2023-07-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-27

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine the neural mechanisms underlying both spontaneous behavior change and behavior change in response to a brief intervention among problem drinkers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although problem drinkers (PD) are a less severe, highly prevalent sub-type of alcohol use disorder (AUD) who are more likely to undergo reductions in alcohol use, compared to more severe AUD, the underlying mechanisms that maintain PD, as well as the mechanisms that underlie both spontaneous and treatment- related behavior change in this population, are not well understood. This proposal takes a lab to life approach by combining functional neuroimaging (fMRI), ecological momentary assessment (EMA), and brief interventions (BI) in non-treatment seeking PD to test whether heightened incentive salience (reactivity) to alcohol cues and impaired ability to regulate cue-induce craving are the mechanisms that characterize PD, and play a role in behavior change vs. persistence of behavior. Identifying these mechanisms is critical for testing and understanding treatments and uncovering who is most likely to respond to interventions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brief Intervention

Participants will receive a brief intervention at week 0

Group Type EXPERIMENTAL

Brief intervention

Intervention Type BEHAVIORAL

A brief motivational intervention with feedback about drinking levels compared to norms

Delayed Intervention

Participants will receive a brief intervention at 6 months

Group Type OTHER

Brief intervention

Intervention Type BEHAVIORAL

A brief motivational intervention with feedback about drinking levels compared to norms

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brief intervention

A brief motivational intervention with feedback about drinking levels compared to norms

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 21-55
* English language fluency
* Over the last 28 days ,Have an average weekly consumption of greater than 14 standard drinks for women, and greater than 24 standard drinks for men.
* Current DSM-V mild or moderate alcohol use disorder (AUD) diagnosis
* Own a smartphone with data plan


* Age 21-55
* English language fluency
* Have an average weekly consumption of less than \</=14 standard drinks for women and less than/equal to 24 standard drinks for men and up to 2 heavy drinking days (\>4/5 standard drinks for a woman/man)
* No lifetime diagnosis of AUD
* owns smartphone with a data plan

Exclusion Criteria

* Past or current severe AUD as defined by DSM- V
* Currently seeking treatment or attempting to stop drinking
* Past or current alcohol withdrawal symptoms
* Current DSM-V diagnosis of substance use disorder (other than nicotine or caffeine).
* Regular use (more than 1-2 times weekly) of recreational drugs.
* Psychotic Disorder or Bipolar disorder
* Severe depression (Patient Health Questionnaire score \> 19) or anxiety (Beck Anxiety Inventory \> 25)
* Substantial risk of suicide or violence
* MRI contraindications (e.g., metallic implants, pacemaker, weight \> 350 lbs, waist \> 55")
* Hearing impaired/hearing aids, unable to read newspaper at arm's length with corrective
* Objective cognitive impairment
* Current or recent (evidence of disease x 5 years) non-skin neoplastic disease or melanoma. - Active hepatic disease (not a history of hepatitis) or primary renal disease requiring dialysis, primary untreated endocrine diseases, e.g., Cushing's disease or primary hypothalamic failure or insulin dependent diabetes (Type I or II). Well-treated hypothyroidism will not be excluded.
* Pregnant, lactating (participation allowed 3 months after ceasing lactation), or currently intending to become pregnant
* Any history of ECT
* Brain disorder such as stroke, tumor, infection, epilepsy, multiple sclerosis, degenerative diseases, head injury (LOC \> 5 minutes), mental retardation
* Diagnosed learning disability, dyslexia, or ADHD
* For women: Current pregnancy or intention to be pregnant in the near future
Minimum Eligible Age

21 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwell Health

OTHER

Sponsor Role collaborator

New York State Psychiatric Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nasir Naqvi

research psychiatrist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nasir Naqvi, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Columbia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NYPInstitute

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7390

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Impulsivity Domains and Subjective Response
NCT05929677 RECRUITING EARLY_PHASE1
Anxiety During Abstinence in AUD
NCT06793488 RECRUITING EARLY_PHASE1
Glutamatergic Modulation of Disordered Alcohol Use
NCT02539511 COMPLETED PHASE2/PHASE3
Environment and Alcohol: A Pilot Study
NCT06860607 RECRUITING PHASE1